• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌基质:朋友还是敌人?

Pancreatic cancer stroma: friend or foe?

机构信息

Departments of Medicine and Biochemistry and Molecular Biology, Indiana University School of Medicine, Melvin and Bren Simon Cancer Center and Pancreatic Cancer Signature Center, Indianapolis, IN 46202, USA.

Departments of Medicine and Biochemistry and Molecular Biology, Indiana University School of Medicine, Melvin and Bren Simon Cancer Center and Pancreatic Cancer Signature Center, Indianapolis, IN 46202, USA.

出版信息

Cancer Cell. 2014 Jun 16;25(6):711-2. doi: 10.1016/j.ccr.2014.05.026.

DOI:10.1016/j.ccr.2014.05.026
PMID:24937454
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4821630/
Abstract

Pancreatic cancer desmoplasia is thought to confer biological aggressiveness. In this issue of Cancer Cell, Özdemir and colleagues and Rhim and colleagues demonstrate that targeting the stroma results in undifferentiated, aggressive pancreatic cancer that responds to checkpoint blockade or antiangiogenic therapy, uncovering a protective role by stroma in this cancer.

摘要

胰腺癌的促结缔组织增生被认为是具有侵袭性的生物学特征。在本期《癌细胞》杂志中,Özdemir 及其同事以及 Rhim 及其同事表明,靶向基质会导致未分化的侵袭性胰腺癌对检查点阻断或抗血管生成治疗产生反应,揭示了基质在这种癌症中的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/4821630/31fdefd9b181/nihms770406f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/4821630/31fdefd9b181/nihms770406f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48df/4821630/31fdefd9b181/nihms770406f1.jpg

相似文献

1
Pancreatic cancer stroma: friend or foe?胰腺癌基质:朋友还是敌人?
Cancer Cell. 2014 Jun 16;25(6):711-2. doi: 10.1016/j.ccr.2014.05.026.
2
[Pancreatic cancer stroma: oncologist's ally or foe?].[胰腺癌间质:肿瘤学家的盟友还是敌人?]
Z Gastroenterol. 2015 Apr;53(4):337-8. doi: 10.1055/s-0034-1398955. Epub 2015 Apr 10.
3
Disrupting the balance between tumor epithelia and stroma is a possible therapeutic approach for pancreatic cancer.破坏肿瘤上皮细胞与基质之间的平衡是一种治疗胰腺癌的可能方法。
Med Sci Monit. 2014 Oct 20;20:2002-6. doi: 10.12659/MSM.892523.
4
Stroma and pancreatic ductal adenocarcinoma: an interaction loop.基质与胰腺导管腺癌:一个相互作用循环。
Biochim Biophys Acta. 2012 Aug;1826(1):170-8. doi: 10.1016/j.bbcan.2012.04.002. Epub 2012 Apr 13.
5
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.癌症相关成纤维细胞亚群:胰腺癌基质靶点的新来源
Trends Cancer. 2019 Nov;5(11):724-741. doi: 10.1016/j.trecan.2019.09.010. Epub 2019 Oct 21.
6
Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.胰腺癌干细胞可能定义胰腺导管腺癌中肿瘤基质特征和复发模式。
BMC Cancer. 2021 Apr 9;21(1):385. doi: 10.1186/s12885-021-08123-w.
7
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.胰腺癌中的肿瘤-基质相互作用与组织纤维化。
Mol Cancer. 2019 Jan 21;18(1):14. doi: 10.1186/s12943-018-0927-5.
8
Subtyping Pancreatic Cancer.胰腺癌分型。
Cancer Cell. 2015 Oct 12;28(4):411-413. doi: 10.1016/j.ccell.2015.09.020.
9
Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.胰腺癌-基质相互作用中的关键参与者:癌症相关成纤维细胞、内皮细胞和炎症细胞。
World J Gastroenterol. 2016 Mar 7;22(9):2678-700. doi: 10.3748/wjg.v22.i9.2678.
10
Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.通过卵巢型间质区分的胰腺导管内乳头状黏液性肿瘤和黏液性囊性肿瘤。
Surgery. 2007 Apr;141(4):545-6. doi: 10.1016/j.surg.2006.09.019. Epub 2007 Feb 9.

引用本文的文献

1
Nanotension Relief Agent Enhances Tissue Penetration by Reducing Solid Stress in Pancreatic Ductal Adenocarcinoma via Rho/ROCK Pathway Inhibition.纳米张力缓解剂通过抑制Rho/ROCK通路降低胰腺导管腺癌中的固体应力来增强组织穿透能力。
Biomater Res. 2025 Apr 9;29:0173. doi: 10.34133/bmr.0173. eCollection 2025.
2
Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysis.通过先进的显微镜分析对胰腺导管腺癌(PDAC)肿瘤球体的三维自组织进行定量表征,揭示了细胞类型和基质依赖性。
APL Bioeng. 2025 Mar 27;9(1):016116. doi: 10.1063/5.0242490. eCollection 2025 Mar.
3

本文引用的文献

1
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.耗竭癌相关成纤维细胞和纤维化会诱导免疫抑制,并加速胰腺癌发展,降低患者生存率。
Cancer Cell. 2014 Jun 16;25(6):719-34. doi: 10.1016/j.ccr.2014.04.005. Epub 2014 May 22.
2
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.基质细胞起到抑制而非支持胰腺导管腺癌的作用。
Cancer Cell. 2014 Jun 16;25(6):735-47. doi: 10.1016/j.ccr.2014.04.021. Epub 2014 May 22.
3
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.
胰腺癌中的可塑性与肿瘤微环境:遗传学、代谢及免疫视角
Cancers (Basel). 2024 Dec 6;16(23):4094. doi: 10.3390/cancers16234094.
4
Cancer mutationscape: revealing the link between modular restructuring and intervention efficacy among mutations.癌症突变景观:揭示突变之间模块化重构与干预效果之间的联系。
NPJ Syst Biol Appl. 2024 Jul 13;10(1):74. doi: 10.1038/s41540-024-00398-6.
5
Pancreatic cancer mutationscape: revealing the link between modular restructuring and intervention efficacy amidst common mutations.胰腺癌突变图谱:揭示常见突变中模块化重组与干预疗效之间的联系
bioRxiv. 2024 May 22:2024.01.27.577546. doi: 10.1101/2024.01.27.577546.
6
Microphysiological systems as reliable drug discovery and evaluation tools: Evolution from innovation to maturity.微生理系统作为可靠的药物发现和评估工具:从创新到成熟的演进
Biomicrofluidics. 2023 Dec 28;17(6):061504. doi: 10.1063/5.0179444. eCollection 2023 Dec.
7
Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner.僵硬诱导的癌症相关成纤维细胞以血小板衍生生长因子配体依赖的方式导致免疫抑制。
PNAS Nexus. 2023 Dec 18;2(12):pgad405. doi: 10.1093/pnasnexus/pgad405. eCollection 2023 Dec.
8
Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies.胰腺癌:遗传学、疾病进展、治疗耐药性及治疗策略
J Cancer Metastasis Treat. 2021;7. doi: 10.20517/2394-4722.2021.96. Epub 2021 Nov 5.
9
Phenotype Control techniques for Boolean gene regulatory networks.布尔基因调控网络的表型控制技术。
Bull Math Biol. 2023 Aug 30;85(10):89. doi: 10.1007/s11538-023-01197-6.
10
Nanomedicine Strategies for Targeting Tumor Stroma.靶向肿瘤基质的纳米医学策略
Cancers (Basel). 2023 Aug 17;15(16):4145. doi: 10.3390/cancers15164145.
预计 2030 年美国癌症发病与死亡人数:甲状腺癌、肝癌和胰腺癌带来的意外负担。
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.
4
A starring role for stellate cells in the pancreatic cancer microenvironment.星状细胞在胰腺癌微环境中的突出作用。
Gastroenterology. 2013 Jun;144(6):1210-9. doi: 10.1053/j.gastro.2012.11.037.
5
Genetically engineered mouse models of pancreatic adenocarcinoma.胰腺导管腺癌的基因工程小鼠模型。
Mol Oncol. 2013 Apr;7(2):232-47. doi: 10.1016/j.molonc.2013.02.002. Epub 2013 Feb 11.
6
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.酶靶向基质消融消除了治疗胰腺导管腺癌的物理屏障。
Cancer Cell. 2012 Mar 20;21(3):418-29. doi: 10.1016/j.ccr.2012.01.007.
7
Definition and classification of cancer cachexia: an international consensus.癌症恶病质的定义和分类:国际共识。
Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4.
8
Targeting angiogenesis in pancreatic cancer: rationale and pitfalls.靶向胰腺癌血管生成:原理与陷阱
Langenbecks Arch Surg. 2008 Nov;393(6):901-10. doi: 10.1007/s00423-008-0280-z. Epub 2008 Jan 22.